1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Modi-1 Moditope: new trials by email Literature Review of Modi-1 Moditope trials Research Report on Modi-1 Moditope
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer Modi-1 Moditope, Pembrolizumab, MicronJet600™ microneedle device (NanoPass) - Triple Negative Breast Cancer, Renal Cell Cancer | Phase 1 / Phase 2 | Recruiting | Scancell Ltd | 168 | 2022-04-07 | 2025-09-17 |
Carcinoma, Renal Cell (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
Scancell Ltd (1)
United Kingdom (1)